Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-patch domain-containing protein 4 is a protein with an N-terminal G-patch domain and a coiled coil region, primarily localized to the nucleolus and nucleoplasm in human cells[2][3][5]. It binds RNA and interacts with nucleolar proteins, including DDX21, and plays a critical role in ribosome biogenesis by regulating rRNA transcription and nucleolar R-loop homeostasis[2][1][5]. Loss of GPATCH4 impairs cell growth, alters nucleolar structure, and reduces protein synthesis, likely due to incomplete 2′-O-methylation of rRNA and compromised nucleolar organization[2][1]. Amplification and high expression of GPATCH4 have been implicated in hepatocellular carcinoma, where it contributes to cancer cell proliferation[2][3]. GPATCH4 is not a receptor, transporter, enzyme, or ion channel, but rather a nucleolar RNA-binding regulatory protein[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-patch domain-containing protein 4 (GPATCH4).